Medicaid enrollees with type 2 diabetes face restricted access to newer classes of first-line medications, especially in ...

Mississippi Attorney General Lynn Fitch is warning Mississippians of unapproved and compounded weight loss drugs.

Hims & Hers Health, Inc.'s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the impact of drug access, ...

Weight-loss medications such as Ozempic, Wegovy, and Mounjaro have attracted widespread attention, making headlines across ...

Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.

Gov. Glenn Youngkin saved about $7 million in state funds and $40 million in federal funds by vetoing a lower body-mass index ...

The Ohio Board of Pharmacy recently revoked the licenses of four Ohio medical spas, with concerns over the sourcing and ...

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

T he battle between weight-loss drugs continues. While studies show semaglutide (sold under the brand names Ozempic and ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

Mounjaro is a prescription injection, often used off-label for weight loss, that is administered under the skin to patients struggling with obesity and weight loss. Off-label means that the actual use ...

(Reuters) -The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...